N-[2-(4-methylpiperidin-1-yl)ethyl]-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
Chemical Structure Depiction of
N-[2-(4-methylpiperidin-1-yl)ethyl]-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
N-[2-(4-methylpiperidin-1-yl)ethyl]-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide
Compound characteristics
| Compound ID: | L707-1436 |
| Compound Name: | N-[2-(4-methylpiperidin-1-yl)ethyl]-2-[7-(morpholine-4-sulfonyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetamide |
| Molecular Weight: | 492.64 |
| Molecular Formula: | C24 H36 N4 O5 S |
| Smiles: | CC1CCN(CC1)CCNC(CN1C(CCCc2cc(ccc12)S(N1CCOCC1)(=O)=O)=O)=O |
| Stereo: | ACHIRAL |
| logP: | 1.6604 |
| logD: | 0.2814 |
| logSw: | -2.6438 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 83.865 |
| InChI Key: | YRXLFPTWTFVVIT-UHFFFAOYSA-N |